VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

One-year results from the company's FORWARD-101 trial of islet cell therapy zimislecel (also known as VX-880) showed that all ...

A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

A revolutionary stem cell therapy has helped Amanda Smith ditch insulin injections for good, offering new hope to diabetics ...

One of the first brain cells shown to make insulin is the neurogliaform cell. These live in a brain area important for ...

Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...

Amanda Smith has kicked insulin to the curb in what experts are calling a milestone in the fight against Type 1 diabetes.

A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain ...

Australia: A recent multicentre audit conducted in Queensland, Australia, has provided compelling real-world evidence ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...